SCHEMBL3485848

SCHEMBL3485848

Cc1nc(C)c(=O)[nH]c1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.45
ALDH1A1 P00352 1/20 0.45
NSD2 O96028 1/20 0.39
CASP6 P55212 1/20 0.39
TYMP P19971 1/20 0.39
CYP1A2 P05177 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PNP P00491 1/20 0.33
MAPK1 P28482 1/20 0.33
PARP1 P09874 1/20 0.32
XDH P47989 1/20 0.32
RAB9A P51151 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
GAA P10253 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
POLB P06746 1/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12465419 0.74 ALDH1A1 (0.37) L3MBTL1ALDH1A1NSD2CASP6TYMP
SCHEMBL3094877 0.74 NSD2 (0.42) L3MBTL1ALDH1A1NSD2CASP6CYP1A2
SCHEMBL3956367 0.70
SCHEMBL16631736 0.70 NSD2 (0.39) L3MBTL1ALDH1A1NSD2CASP6PARP1
SCHEMBL1901369 0.67 LTB4R (0.49) ALDH1A1PNPPARP1CYP2C9GAA
SCHEMBL10926121 0.67 NSD2 (0.41) L3MBTL1ALDH1A1NSD2CASP6PARP1
SCHEMBL29819457 0.66 KDM4E (0.51) ALDH1A1NSD2CASP6CYP1A2NPSR1
SCHEMBL18081737 0.65 NSD2 (0.36) L3MBTL1ALDH1A1NSD2CASP6CYP1A2
SCHEMBL13007576 0.65 SMN1; SMN2 (0.40) L3MBTL1ALDH1A1NSD2CASP6CYP1A2
SCHEMBL12547436 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100015708-A1 RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF MDRNA, INC. (US) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100015708-A1 RIBONUCLEIC ACIDS WITH NON-STANDARD BASES AND USES THEREOF NSUN2, NSUN3, RNMT L3MBTL1 38/4885ALDH1A1 1958/4885NSD2 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.